Liraglutide Solution Injection - Purity: 99%

Liraglutide is a prescription medication used primarily for the treatment of type 2 diabetes, obesity, and sometimes for cardiovascular risk reduction in diabetic patients. It is a GLP-1 receptor agonist, which mimics the hormone glucagon-like peptide-1 to regulate blood sugar levels and appetite. Liraglutide is administered as a subcutaneous injection.


Liraglutide Injection: Overview
Liraglutide is a prescription medication used primarily for the treatment of type 2 diabetes, obesity, and sometimes for cardiovascular risk reduction in diabetic patients. It is a GLP-1 receptor agonist, which mimics the hormone glucagon-like peptide-1 to regulate blood sugar levels and appetite. Liraglutide is administered as a subcutaneous injection.

Common Brand Names:
Victoza: For type 2 diabetes management.
Mechanism of Action:
Liraglutide works by:

Stimulating insulin secretion in response to high blood glucose.
Suppressing glucagon release to prevent excess glucose production.
Slowing gastric emptying, which helps control appetite and supports weight loss.
Uses:
Type 2 Diabetes:

Improves glycemic control when used alongside diet and exercise.
Often prescribed if other diabetes medications like metformin are insufficient.
Obesity and Weight Management:

Indicated for adults with a BMI a Y30 or a Y27 with weight-related conditions (e.g., hypertension, dyslipidemia).
Helps reduce appetite and caloric intake.
Cardiovascular Risk Reduction:

Shown to reduce the risk of major cardiovascular events (e.g., stroke, heart attack) in patients with type 2 diabetes.
Dosage:
Initial dose is usually 0.6 mg/day, increased weekly based on tolerance and treatment goals.
Maximum doses:
1.8 mg/day for diabetes (Victoza).
3.0 mg/day for weight management.